About us
We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities. Read more....

Albendazole Donation Programme.
In support of the London NTD Declaration goals, GlaxoSmithKline (GSK) expanded its significant albendazole donation programme which targets two neglected diseases and has strengthened its commitment to support R&D efforts. GSK pledged to extend by an additional five years its commitment to donate 400 million albendazole tablets each year to the WHO to enable de-worming of school age children in all endemic countries. Expanding this programme, which was initially planned to run to 2015, will equate to an additional two billion tablets of albendazole being donated up to 2020. Read more...